News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alimera Sciences Expects IPO to Raise About $87 Million



4/19/2010 7:09:36 AM

AP -- Alimera Sciences Inc., a biopharmaceutical company that specializes in prescription eye drugs, plans an initial public offering of its stock this week. Alimera is conducting two late-stage clinical trials for Iluvien, which aims to treat diabetic macular edema, a retinal disease that can lead to blindness. The company called Iluvien its most advanced drug candidate.

Read at AP
Read at News Release


comments powered by Disqus
AP
News Release
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES